IVIG (Intravenous Immunoglobulin) Market: High-Growth Emerging Economies And The Companies That Propel Them [Baxter International Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BD

IVIG market (Intravenous Immunoglobulin Market) was valued at $7,861 million, and is expected to reach $12,632 million by 2022, supported by a CAGR of 7.1%. Immunoglobulins (IGs) are glycoproteins produced in the blood plasma in response to the antigens, which are foreign to the host system. They are highly complex entities and specific in their action. They are obtained from blood by fractionation process and purified for therapeutic and non-therapeutic applications. In therapeutics, they are administered intravenously in the treatment of various deficiencies.

Download PDF Report sample @ https://www.alliedmarketresearch.com/request-sample/325

IVIG market is driven by the increase in prevalence of chronic inflammatory demyelinating polyneuropathy and hypogammaglobulinemia, and rise in use of immunoglobulins to treat GuillainBarre syndrome, inflammatory myopathies, specific antibody deficiency, and others. Further, the increase in approval of intravenous immunoglobulin (IVIG) drugs from the Food and Drug Administration (FDA), European Medicine Agency (EMA), and government is expected to accelerate the sales of immunoglobulin.

Increase in geriatric population and hemophilic patients, improved IVIG production owing to the emergence of advanced technologies, and enhanced purification techniques (with better plasma yield) are the other key factors that contribute to the IVIG market growth. In addition, the market is restrained by the stringent government regulations, high cost of therapy, and high risk of side effects associated with the use of IVIG.

North America currently dominates the IVIG market, in terms of revenue, followed by Asia-Pacific owing to high adoption of its treatments, high plasma collection, and large patient population. LAMEA is expected to grow at a high CAGR of 10% owing to the rise in preference of IVIG therapies and growth in awareness about immunodeficiency diseases in underdeveloped regions.

Key players operating in the IVIG market are

Baxter international Inc.,
CSL Ltd,
Grifols S.A,
Octapharma AG,
Kedrion Biopharma Inc.,
LFB group,
Biotest AG,
China Biologics Products, Inc.,
BDI Pharma Inc., and Bayer Healthcare.

Get Customized Report as Required @ https://www.alliedmarketresearch.com/request-for-customization/325

Chapter: 1. INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS:
1.3. KEY MARKET SEGMENTS:
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst tools and models


Chapter: 2. EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE


Chapter: 3. MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. OVERVIEW OF IVIG

3.2.1. Patented products

3.3. EPIDEMIOLOGY AND ECONOMIC BURDEN OF CHRONIC CONDITIONS
3.4. COST OF SIDE EFFECTS DUE TO IVIG TREATMENTS
3.5. KEY FINDINGS

3.5.1. Top Factors Impacting global IVIG market
3.5.2. Top Investment PocketsGlobal IVIG Market

3.6. PORTERS FIVE FORCES ANALYSIS

3.6.1. Bargaining power of buyers (Low)
3.6.2. Bargaining power of suppliers (Low)
3.6.3. Threat of new entrants (low)
3.6.4. Threat of substitutes (low)
3.6.5. Intense competitive rivalry (moderate)

3.7. VALUE CHAIN ANALYSIS

3.7.1. Primary activities
3.7.2. Support Activities

3.8. MARKET SHARE ANALYSIS (2014)
3.9. PRODUCT SCENARIO IN IVIG MARKET
3.10. GOVERNMENT REGULATIONS AND REIMBURSEMENTS

3.10.1. IVIG regulations in United States and Europe
3.10.2. Reimbursements Scenario

3.11. INDICATIONS FOR IVIG

3.11.1. USFDA Indications

3.11.2. EMA

3.12. COMPONENT ANALYSIS OF IMMUNOGLOBULIN G (IGG)

3.12.1. IgG1
3.12.2. IgG2
3.12.3. IgG3
3.12.4. IgG4

3.13. CLINICAL TRIALS
3.15. MARKET DYNAMICS

3.15.1. Drivers
3.15.2. Restraints
3.15.3. Opportunities

Enquiry Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/325

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

Shriram Dighe
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.